‘Pharmacy teams are overwhelmed by the sheer workload’

Pharmacy teams should have a disaster plan to combat the impact of a second wave of COVID-19, says a mental health expert

harpreet%20chana.jpg

The second wave of COVID-19 is sweeping through the UK, following one that pushed pharmacies across the country to the brink, raising the question of whether pharmacy professionals will be able to weather the pressure once more.

In the latest C+D podcast, Harpreet Chana, founder of the Mental Wealth coaching academy, discusses the long-term mental health effects of COVID-19 on the pharmacy team with C+D clinical editor Naimah Callachand.

“I'm hearing a lot from colleagues that they feel absolutely overwhelmed by the sheer amount of work they've got to do,” she says. The podcast offers a new follow-up interview with Ms Chana after her appearance on C+D’s webinar on September 24 at the Clinical Pharmacy Congress, which explored the range of effects of ‘long COVID’ on patients.

From a mental health perspective, the next six months for pharmacy professionals are “a really stark prospect”, Ms Chana says in the new podcast. The second wave could bring the problems seen in spring of stress, staff shortages and financial pressures, she says.

Learning from their experiences from the last six months, pharmacy teams should collaborate on a “disaster recovery or contingency plan” to prepare for how they would cope with increased patient demand, she says.

“There are certain things that we can put in place now, to ensure that some of the things that caught us off-guard last time we can prepare ourselves [for] this time,” she says.

Measures could include protecting staff wellbeing through regular breaks. Advising patients against stockpiling items, which Ms Chana has seen a surge of recently, is an important part of the role of pharmacy teams, she says.

Pharmacy teams can access additional support and resources from Pharmacist Support, as well as other mental health charities such as Mind.

You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts on iTunes or by searching “Chemist+Druggist podcast” on your preferred Android podcast app.

Please note, the sound quality of this podcast may be affected as it has been recorded remotely during the COVID-19 outbreak.

Sign in or register for free

Latest from Analysis

What role will pharmacists play in the eternal pursuit of a longer life?

 
• By 
 • comment0

The desire to stop aging has always persisted. Could pharmacists help this be a gold rush bigger than the proliferation of weight loss drugs?

Contract: It’s fair to say the deal agreed is simply not enough

 
• By 
 • comment2

It is a step forward, but set against the backdrop of the economic analysis it’s just not enough to help community pharmacy release itself from the financial blackhole it has been placed in.

More from Coronavirus

COVID-19 vaccination fees stagnate despite negotiator pleas

 
• By 
 • comment

Confirmation of the unchanging fees comes as NHS England (NHSE) has asked pharmacies to prepare for the autumn flu and COVID-19 vaccination programmes to start in October, or September for pregnant women.  

exclusive

Novavax COVID jab delivered by indie pharmacy in UK first

 
• By 
 • comment

The new private COVID-19 vaccine, manufactured by Novavax and delivered for the first time in the UK by an independent pharmacy, is almost half the price of the Pfizer jab offered by Boots.